Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2019 1
2021 2
2022 1
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Incidence and risk factors for moderate/severe COVID-19 in rheumatic diseases patients on hydroxychloroquine: a 24-week prospective cohort.
Pinheiro MM, Pileggi GS, Kakehasi AM, Gomides Reis APM, Reis-Neto ET, Abreu MM, Albuquerque CP, Araújo NC, Bacchiega AB, Bianchi DV, Bica B, Bonfa E, Borba EF, Egypto Brito DCS, Calderaro DC, Pinto Duarte ÂLB, Espírito Santo RC, Fernandes PR, Guimarães MP, Poti Gomes KW, Faustino Ilana GG, Klumb EM, Marques CDL, Guedes de Melo AK, Monticielo OA, Mota LMH, Munhoz GA, Paiva ES, Pereira HLA, Provenza JR, Ribeiro SLE, Rocha LF Jr, Sato EI, Skare T, de Souza VA, Valim V, Lacerda MVG, Xavier RM, Ferreira GA. Pinheiro MM, et al. Among authors: bianchi dv. Clin Exp Rheumatol. 2022 Jul;40(7):1258-1266. doi: 10.55563/clinexprheumatol/67oyux. Epub 2021 Jul 7. Clin Exp Rheumatol. 2022. PMID: 34251312 Free article.
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study.
Elhai M, Boubaya M, Distler O, Smith V, Matucci-Cerinic M, Alegre Sancho JJ, Truchetet ME, Braun-Moscovici Y, Iannone F, Novikov PI, Lescoat A, Siegert E, Castellví I, Airó P, Vettori S, De Langhe E, Hachulla E, Erler A, Ananieva L, Krusche M, López-Longo FJ, Distler JHW, Hunzelmann N, Hoffmann-Vold AM, Riccieri V, Hsu VM, Pozzi MR, Ancuta C, Rosato E, Mihai C, Kuwana M, Saketkoo LA, Chizzolini C, Hesselstrand R, Ullman S, Yavuz S, Rednic S, Caimmi C, Bloch-Queyrat C, Allanore Y; for EUSTAR network. Elhai M, et al. Ann Rheum Dis. 2019 Jul;78(7):979-987. doi: 10.1136/annrheumdis-2018-214816. Epub 2019 Apr 9. Ann Rheum Dis. 2019. PMID: 30967395
Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil.
Pileggi GS, Ferreira GA, Reis APMG, Reis-Neto ET, Abreu MM, Albuquerque CP, Araújo NC, Bacchiega AB, Bianchi DV, Bica B, Bonfa ED, Borba EF, Brito DCSE, Duarte ÂLBP, Santo RCE, Fernandes PR, Guimarães MP, Gomes KWP, Kakehasi AM, Klumb EM, Lanna CCD, Marques CDL, Monticielo OA, Mota LMH, Munhoz GA, Paiva ES, Pereira HLA, Provenza JR, Ribeiro SLE, Junior LFR, Sampaio CSJC, Sampaio VS, Sato EI, Skare T, de Souza VA, Valim V, Lacerda MVG, Xavier RM, Pinheiro MM. Pileggi GS, et al. Among authors: bianchi dv. Adv Rheumatol. 2021 Oct 7;61(1):60. doi: 10.1186/s42358-021-00217-0. Adv Rheumatol. 2021. PMID: 34620246 Free PMC article.